SenzaGen investor relations material

Listen to the latest call from SenzaGen

SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers modified human cell lines that can be induced to react with a wide variety of chemicals and cell genes that may be activated by specific substances. SenzaGen AB was incorporated in 2000 and is based in Lund, Sweden. As of February 19, 2016, SenzaGen AB operates as a subsidiary of Ascendis Pharma A/S.

  • Ticker

    SENZA
  • Country

    SE

Dig deeper into the SenzaGen fundamentals on Quartr.